Two weeks after becoming legal in California, sales of recreational marijuana are about to start in Los Angeles.
Cannabis News
Anandia Labs Closes $13.4 Million Private-Placement Financing
Anandia Laboratories Inc, a leading cannabis biotechnology and testing company, is pleased to announce that it has closed a private placement financing of common shares of CAD$13.4 million at a post-money valuation of CAD$63 million.
Cannabis Wheaton Income Corp. Accelerates Warrant Expiry Date for Anticipated Proceeds of $57.7 Million
Cannabis Wheaton Income Corp. (TSX-V:CBW) announced today that the Company has elected to exercise its right under the warrant indenture governing the common share purchase warrants of the Company issued on June 29, 2017.
Aurora Cannabis Completes Cornerstone Investment in The Green Organic Dutchman
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and The Green Organic Dutchman Holdings Ltd. (privately held) today announced that the companies have completed Aurora's strategic investment in TGOD, as previously announced on January 5, 2018.
MPX Appoints New Chief Financial Officer
MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren as the Company’s new Chief Financial Officer, effective January 15, 2018, subject to regulatory approval.
Aurora Cannabis Completes Strategic Investment in Micron Waste Technologies
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Micron Waste Technologies Inc. (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), a developer of proprietary digester solutions for the treatment of organic waste, today announced that Aurora has completed a strategic investment in Micron and that the companies have finalized a collaboration agreement pursuant to which both companies will collaborate on the optimization of Micron's technology for the treatment of organic waste generated in the cultivation and production of cannabis products.
‘Cellular Agriculture’ Could Be the Future of Cannabis - Leafly
Cellular agriculture, like biosynthesis more broadly, also suits pharmaceutical companies that “need purity in these products,” said Eric Adams. Adams is the CEO of one such company, InMed Pharmaceuticals, based in Vancouver, B.C. The process “lets us control these rare cannabinoids and make them pesticide-free.”
Aphria strengthens portfolio with acquisition of leading West Coast producer Broken Coast
With Broken Coast, Aphria becomes the largest Canadian EBITDA generating Licensed Producer. Creates leading cross-Canada platform, with scaled low cost greenhouse operations in Ontario and award-winning premium indoor BC production
MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and Marketing of Pharma-Grade Cannabinoid Products
MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that further to its press release dated August 22, 2017, it has entered into a definitive agreement with Panaxia Pharmaceutical Industries Ltd. through its wholly-owned subsidiary Salus BioPharma Corporation, a company engaged in the business of development and production of pharma grade cannabidiol medicinal products, medicinal preparations and medicinal accessories.
Aphria Continues Expansion into Australia with Strategic Investment in Althea Company Pty Ltd.
Aphria Inc (TSX: APH and US OTC: APHQF) today announced that it has signed a supply agreement with Australian-based Althea Company Pty Ltd. and invested $2.5 million in Althea in exchange for 25% shareholdings in the Company. The investment increases Aphria's presence in the emerging Australian cannabis market.
GrowGeneration Raises $9.0 Million in Growth Capital
Company Increases 2018 Revenue Guidance To Over $30 Million
Emblem Announces $50 Million Bought Deal
Emblem Corp. (TSX VENTURE:EMC)(TSX VENTURE:EMC.WT) is pleased to announce that it has entered into a letter of engagement with Eight Capital pursuant to which Eight Capital has agreed to purchase 12,195,123 units and 25,000 convertible unsecured debentures of the Company, on a "bought deal" basis
Will New York Finally Consider Legalizing Cannabis This Week?
A panel of lawmakers will now hear testimony from some of the state's most experienced advocates for reform. On Thursday morning, the New York State Assembly Standing Committees on Codes, Health, and Alcohol and Drug Abuse will convene a public hearing to discuss the Marijuana Regulation and Taxation Act (MRTA), aimed to legalize the use, distribution, and production of cannabis for adults aged 21 and over.
Copy of Dr. Michael Nashat Appointed President & CEO of TerrAscend
TerrAscend Corp. (CSE: TER) is pleased to announce the appointment of TerrAscend's co-founder and Chief Operating Officer, Dr. Michael Nashat, as the Company's new President & Chief Executive Officer, effective January 22, 2018.
Newstrike’s Up Cannabis Enters Into Exclusive Partnership with Canada's Leading Entertainment Group The Feldman Agency
The Feldman Agency will work with Up Cannabis to create strategic partnerships in the music and entertainment space, respecting federal regulations governing the legalized cannabis market.